clearn.png
Wednesday December 8th, 2021 11:16PM

BioNTech boss strikes upbeat note on Europe's vaccine drive

By The Associated Press
Related Articles
  Contact Editor

BERLIN (AP) — More than half of Europe's population should have received the coronavirus vaccine in the next two months, allowing governments to consider easing lockdown rules for those who've been immunized, the head of German pharmaceutical company BioNTech said Wednesday.

The European Union has lagged behind Britain and the United States in the race to get shots into arms, but in recent weeks the pace of vaccinations has picked up significantly.

Ugur Sahin, whose company developed the first widely approved shot against COVID-19 with U.S. partner Pfizer, predicted that “50-60% of the population will have received the vaccine" by the end of June, at which point any easing of pandemic restrictions would affect a broad swath of the population.

He cited studies from Israel, which shares medical data on its vaccination campaign with Pfizer, showing that people who have been immunized rarely fall seriously ill and are significantly less likely to transmit the virus to others.

Sahin suggested Europe could reach herd immunity "in July, latest by August,” but cautioned that children would still be among those at risk as the vaccine has so far only been approved for people over 16. A small number of children who fall ill with COVID-19 suffer serious illness or long-term effects.

While the exact threshold required to reach that critical level of immunization remains a matter of debate, experts say a level above 70% would significantly disrupt transmission of the coronavirus within a population.

BioNTech's vaccine makes up a large share of the doses administered in North America, where it is more commonly known as the Pfizer shot, and the EU, which is poised to place a massive, multi-year order of 1.8 billion doses in the coming days.

Sahin said data from people who have received the vaccine show that the immune response gets weaker over time, and a third shot will likely be required.

Studies show the efficacy of the BioNTech-Pfizer vaccine declines from 95% to about 91% after six months, he said.

“Accordingly, we need a third shot to get the vaccine protection back up to almost 100% again” Sahin told reporters during a video call.

Vaccine recipients currently receive a second dose three weeks after their first shot, although some countries have longer intervals. Sahin suggested the third should be administered nine to 12 months after the first shot.

“And then I expect it will probably be necessary to get another booster every year or perhaps every 18 months,” he said.

Concerns have been raised that existing vaccines might be less effective against new variants of the virus now emerging in different parts of the world.

Sahin said BioNTech has tested its vaccine against more than 30 variants, including the now-dominant one first detected in Britain, and found the shot triggers a good immune response against almost all of them in the lab. In cases where the immune response was weaker, it remained sufficient, he said, without providing exact figures.

Asked about the new variant first detected in India, Sahin said the vaccine's effectiveness against it was still being investigated.

“But the Indian variant has mutations that we have previously investigated and against which our vaccine also works, so I am confident there, too,” he said.

“The vaccine is quite cleverly constructed, and the bulwark will hold. I'm convinced of that," Sahin said. “If the bulwark needs to be strengthened again, we'll do so. I'm not worried.”

The company is investigating reports of heart inflammation cases in people who received the vaccine in Israel, but so far hasn't seen any data that would indicate a heightened risk, Sahin said. Some 5 million people in Israel have been vaccinated, primarily with the BioNTech/Pfizer shot, giving it one of the highest coverages in the world.

“We take everything we hear very seriously,” Sahin said. “The most important principle in drug development is to do no harm.”

BioNTech expects to receive approval in July for its vaccine to be used in China, where it cooperates with local firm Fosun Pharma, he said.

Meanwhile, BioNTech and Pfizer are working with other manufacturers to ramp up production of the mRNA shot as worldwide demand still far outstrips supply.

“When we started 2021, our goal was to produce 1.3 billion doses, and now we've increased that to 3 billion doses,” said Sahin, praising pharmaceutical giants such as Novartis, Sanofi and Baxter for joining in the effort.

His company is in talks to create production facilities in Asia, South America and Africa, and may also issue special licenses to other “really competent” manufacturers to boost global supply of the vaccine, Sahin said.

“We don't want to have a low-quality vaccine in Africa,” he added, dismissing suggestions that the recipe for it could simply be made freely available.

Countering fierce criticism that the European Union had bungled its vaccine procurement process, Sahin said the 27-nation bloc deserved praise for managing to coordinate the simultaneous delivery of the first batches to all member states at the end of December.

“Europeans can be proud that they found a fair solution,” he said, adding that the bloc also exported large numbers of doses elsewhere.

“It doesn't help if Europeans are safe and other countries, where the virus is still raging, keep churning out new variants,” he said.

Sahin founded BioNTech in 2008 with his wife, the scientist Ozlem Tureci. Together they decided to pivot from cancer research to developing a coronavirus vaccine in early 2020 and reached out to Pfizer, which had the necessary expertise to conduct large-scale clinical trials.

The 55-year-old, whose family emigrated from Turkey to Germany when he was 4, told members of Germany's foreign press association VAP that it was "a very nice feeling” to be hearing of more and more people who are able to finally see loved ones again after getting vaccinated with his company's shot.

Sahin said he expects a “new normal” soon, where “one can move about freely and most people have a very good immune protection” against the virus.

Even so, some would either not want to get vaccinated or have a weak immune system “and we have to consider these people too,” he said.

___

Follow AP’s pandemic coverage at:

https://apnews.com/hub/coronavirus-pandemic

https://apnews.com/hub/coronavirus-vaccine

https://apnews.com/UnderstandingtheOutbreak

  • Associated Categories: Associated Press (AP), AP Health, AP World News, AP Business, AP Business - Industries, AP Business - Health Care
© Copyright 2021 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
Judge won't release videos of deputies shooting Black man
A judge has denied requests to release body camera video in the case of a Black man who was killed by North Carolina deputies
3:54PM ( 11 minutes ago )
AP sources: Feds search Rudy Giuliani's NYC home, office
A law enforcement official tells The Associated Press that federal investigators have executed search warrants at Rudy Giuliani’s Manhattan residence and office
3:51PM ( 15 minutes ago )
BioNTech boss strikes upbeat note on Europe's vaccine drive
The head of German pharmaceutical company BioNTech says more than half of Europe's population should have received the coronavirus vaccine in the next two months, allowing lockdown rules to be eased
3:48PM ( 18 minutes ago )
Associated Press (AP)
Moldova's president calls early election for July 11
Moldova’s Constitutional Court has canceled a state of emergency introduced to combat COVID-19 infections, enabling President Maia Sandu to dissolve parliament and call for an early election on July 11
3:05PM ( 1 hour ago )
EU report takes aim at Russia over vaccine fake news
A new European Union report says Russia has launched a massive campaign to promote the Sputnik V coronavirus vaccine
3:01PM ( 1 hour ago )
Pacific Northwest faces shutdowns amid rising virus cases
When the coronavirus pandemic hit the Pacific Northwest states of Oregon Washington, their governors quickly reacted with shutdowns
2:37PM ( 1 hour ago )
AP Health
US Navy fires warning shots in new tense encounter with Iran
An American warship fired warning shots when vessels of Iran’s paramilitary Revolutionary Guard came too close to a patrol in the Persian Gulf
2:45PM ( 1 hour ago )
Former members of Italian Red Brigades arrested in France
The French presidency says seven Italians convicted of domestic terrorism crimes have been arrested at their homes in France
2:40PM ( 1 hour ago )
Turkey says it's glad a woman leads EU's executive branch
The Turkish government has again rejected the accusation that it snubbed the head of the European Union’s executive arm because she is a woman and blamed a protocol gaffe on EU squabbling
1:45PM ( 2 hours ago )
AP World News
Astronaut Michael Collins, Apollo 11 pilot, dead of cancer
Apollo 11 astronaut Michael Collins has died at age 90
3:04PM ( 1 hour ago )
Biden to pitch sweeping 'family plan' in speech to Congress
President Joe Biden will use his first joint address to Congress to pitch a $1.8 trillion investment in children, families and education that would transform the role government plays in American life
2:57PM ( 1 hour ago )
Democrats move to reinstate methane rules loosened by Trump
Congressional Democrats are taking action to reinstate regulations designed to limit potent greenhouse gas emissions from oil and gas fields
2:57PM ( 1 hour ago )
AP Business
Stocks pause as investors gauge earnings, await Biden speech
Stocks were little changed in midday trading on Wall Street as investors take in a big wave of earnings reports from major U.S. companies
11:50AM ( 4 hours ago )
Wall Street is off to a mixed start ahead of Biden speech
Stocks are off to a mixed start on Wall Street as investors take in a big wave of earnings reports from major U.S. companies
9:46AM ( 6 hours ago )
BioNTech boss: Europe will reach herd immunity this summer
The head of German pharmaceutical company BioNTech says Europe can achieve herd immunity against the coronavirus "in July, latest by August."
8:40AM ( 7 hours ago )
AP Business - Industries
The Latest: Mexico's pandemic deaths rise above 345,000
Mexico’s pandemic deaths have risen above 345,000, though officials say most states in the country are not seeing any rebound in coronavirus cases
8:55PM ( 19 hours ago )
The Latest: Biden: Sending help to India during virus surge
President Joe Biden says the U.S. is sending “a whole series of help” to India to combat the coronavirus, including life-saving medicines
6:13PM ( 21 hours ago )
The Latest: CDC: Vaccinated can go outside without mask
U.S. health officials say fully vaccinated Americans don’t need to wear masks outdoors unless they are in a big crowd of strangers
12:30PM ( 1 day ago )
AP Business - Health Care
Judge won't release videos of deputies shooting Black man
A judge has denied requests to release body camera video in the case of a Black man who was killed by North Carolina deputies
3:54PM ( 11 minutes ago )
AP sources: Feds search Rudy Giuliani's NYC home, office
A law enforcement official tells The Associated Press that federal investigators have executed search warrants at Rudy Giuliani’s Manhattan residence and office
3:51PM ( 15 minutes ago )
US eyes major rollback in Iran sanctions to revive nuke deal
The Biden administration is weighing a near wholesale rollback of some of the most stringent Trump-era sanctions imposed on Iran, in a bid to get the Islamic Republic to return to compliance with a landmark 2015 nuclear accord
3:46PM ( 20 minutes ago )
In new Electoral College map, shifting battleground dynamics
The 2020 census is shifting the clout of some states in presidential politics
3:41PM ( 25 minutes ago )
Fed keeps key rate near zero, sees inflation as 'transitory'
The Federal Reserve is keeping its ultra-low interest rate policies in place, a sign that it wants to see more evidence of a strengthening economic recovery before it would consider easing its support
3:39PM ( 27 minutes ago )